Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 267-499-7 | CAS number: 67874-71-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2018-09-24 to 2018-10-16
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2019
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 405 (Acute Eye Irritation / Corrosion)
- Version / remarks:
- 2017-10-09
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- signed on 2018-04-26
Test material
- Reference substance name:
- Bismuth tris(2-ethylhexanoate)
- EC Number:
- 267-499-7
- EC Name:
- Bismuth tris(2-ethylhexanoate)
- Cas Number:
- 67874-71-9
- Molecular formula:
- C24H45O6Bi
- IUPAC Name:
- bismuth(3+) tris(2-ethylhexanoate)
- Test material form:
- liquid: viscous
- Details on test material:
- Appearance: brown viscous liquid
Constituent 1
Test animals / tissue source
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or tissues and environmental conditions:
-
TEST ANIMALS
- Source: Charles River Deutschland, 97633 Sulzfeld, Germany
- Age at study initiation: approximately 12 – 13 weeks old
- Weight at study initiation: 2.3 kg
- Housing: individually housed in ABS-plastic or Noryl rabbit cages, floor 4200 cm²
- Diet (ad libitum): autoclaved hay and to Altromin 2123 maintenance diet for rabbits, rich in crude fibre
- Water (ad libitum): tap water
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature: 18 ± 3 °C
- Relative humidity: 55 ± 10%
- Air changes: at least 10 x / hour
- Photoperiod (hrs dark / hrs light): 12/12
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- no
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0.1 ml of the test item applied in the conjunctival sac of one eye. Untreated eye served as control. - Duration of treatment / exposure:
- not applicable
- Observation period (in vivo):
- 1, 24, 48 and 72 hours as well as 4 to 21 days after test item application
- Duration of post- treatment incubation (in vitro):
- not applicable
- Number of animals or in vitro replicates:
- 1 male rabbit
- Details on study design:
- PREPARATION OF THE ANIMALS
Within 24 hours before the test and immediately prior to the application both eyes of the animal were examined.
Approx. 15 hours before the application the eyes were examined with the aid of a fluorescein solution (Fluoreszein SE Thilo®). The eyes were rinsed with physiological saline 0.9 % NaCl after the examination. The animal did not show eye irritation, ocular defects, or pre-existing corneal injury.
INITIAL AND CONFIRMATORY TEST
The in vivo test was performed initially using one animal. The results of the initial test indicated that the test item is corrosive or severe irritant to the eye using the procedure described. Therefore, no additional animals were treated due to animal welfare reasons.
USE OF TOPICAL ANESTHETICS AND SYSTEMIC ANALGESICS
One hour before the application of the test item, 0.01 mg/kg of buprenorphine (Temgesic®) was administered subcutaneously in order to achieve a therapeutic level of systemic analgesia.
Approx. 5 minutes prior to the application of the test item, 1-2 drops of an ocular anaesthetic (Proparakaine-POS® hydrochloride ophthalmic 0.5% solution) were administered in both the treated and the control eye of the animal.
To prevent pain and distress after the application of the test item the animal was treated with doses of buprenorphine and meloxicam to provide a continued therapeutic level of systemic analgesia:
- After test substance application the test animal was dosed with 0.03 mg/kg bw of buprenorphine at the discretion of the veterinarian: 11 hours (day 0) post-application once; day 1 and day 2 twice; day 3 once.
- After test substance application the test animal was dosed with 0.5 mg/kg bw of meloxicam: 8 hours (day 0) up to day 5 and from day 7 up to day 21.
- Day 6, 20 and 21 no analgesic medication.
REMOVAL OF TEST SUBSTANCE
- Washing: treated eye was rinsed with physiological saline 0.9 % NaCl after examination with fluorescein solution
- Time after start of exposure: 1 hour after the application
The eyes were not rinsed to remove residues of the test item, foreign bodies or incrustation 24 hours after application.
SCORING SYSTEM
according to Draize scale
TOOL USED TO ASSESS SCORE: slit lamp biomicroscope / fluorescein
Approximately 15 hours before the application the eyes were examined with the aid of a fluorescein solution.
24 hours post-application and from then on daily until end of the observation period, the treated eye was examined with the aid of a fluorescein solution and a slit lamp biomicroscope. After the examination the eye was rinsed with physiological saline 0.9% NaCl.
OBSERVATIONS
- body weight: prior to the administration, 72 hours after administration and at the end of the observation period
- clinical observations: The eyes were comprehensively evaluated for the presence or absence of ocular lesions one hour and then 24, 48 and 72 hours after application. The eyes were further examined for signs of irritation throughout the observation period.
Results and discussion
In vivo
Resultsopen allclose all
- Irritation parameter:
- cornea opacity score
- Basis:
- mean
- Remarks:
- animal #1
- Time point:
- 24/48/72 h
- Score:
- 1
- Max. score:
- 4
- Reversibility:
- not reversible
- Irritation parameter:
- iris score
- Basis:
- mean
- Remarks:
- animal #1
- Time point:
- 24/48/72 h
- Score:
- 1.33
- Max. score:
- 2
- Reversibility:
- not reversible
- Irritation parameter:
- chemosis score
- Basis:
- mean
- Remarks:
- animal #1
- Time point:
- 24/48/72 h
- Score:
- 1.33
- Max. score:
- 4
- Reversibility:
- not reversible
- Irritation parameter:
- conjunctivae score
- Basis:
- mean
- Remarks:
- animal #1
- Time point:
- 24/48/72 h
- Score:
- 1.67
- Max. score:
- 3
- Reversibility:
- not reversible
- Irritant / corrosive response data:
- Animal # 1:
- conjunctival redness score 1 one hour post-application. 24 hours post-application a conjunctival redness score 2 was observed before the score decreased to 1 from 72 hours until 12 days post-application. No conjunctival redness was detected 13 days after installation of the test item. 14 to 21 days after dosing the animal showed conjunctival redness score 1. The effect was not fully reversible within the observation period of 21 days after application of the test material. The mean score of animal no. 1, following grading at 24, 48 and 72 h after installation of Bismuth tris (2-ethylhexanoate), was calculated to be 1.66.
- conjunctival chemosis score 3 one hour and score 2 24 hours post-application. From 72 hours to 11 days post-administration of the test material conjunctival chemosis was assessed with score 1. 12 days after test item installation score 2 was observed, before the score decreased again to 1 from 13 days post-application until end of the observation period. The effect was not fully reversible within the 21 days-observation period. The mean score of animal no. 1, following grading at 24, 48 and 72 h after installation of Bismuth tris (2-ethylhexanoate), was calculated to be 1.33.
- Iris lesion score 1 one hour post-application and score 2 24 hours post-application. From 72 hours until end of the observation period iris lesion score 1 was observed in the tested animal. The effect was not fully reversible within the observation period of 21 days after dosing. The mean score of animal no. 1, following grading at 24, 48 and 72 h after installation of Bismuth tris (2-ethylhexanoate), was calculated to be 1.33.
- Cornea opacity score 1 throughout the 21 days-observation period. The effect was not fully reversible within the test period. The mean score of animal no.1, following grading at 24, 48 and 72 h after installation of the test material, was calculated to be 1.00.
Local effects were observed in animal #1:
The observed local effects comprised slight to moderate hypersecretion, half eyelid closure and incline of the head.
Upon fluorescein examinations starting 24 hours post-application, the treated eyes of animal no. 1 showed corneal daily lesions (starting with approx. 100% of the area) until 12 days post-application. From 13 days to 19 days after administration of the test item no stainable lesions were recorded in the test animal, while from 20 days to 21 days post-application slightly visible changes in the cornea were apparent (approx. 10% of the area). - Other effects:
- - clinical observations: neither mortality nor significant clinical signs of toxicity were observed.
- body weight: the body weight development was within the expected range.
Applicant's summary and conclusion
- Interpretation of results:
- Category 1 (irreversible effects on the eye) based on GHS criteria
- Conclusions:
- The substance is serious eye damaging.
According to Annex I of Regulation (EC) 1272/2008 and subsequent adaptations, the test item Bismuth tris (2-ethylhexanoate) has to be classified as serious eye damaging (Category 1).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.